Insulin Glargine Lixisenatide

Save $1,043/mo

3× cheaper

A once-daily combination of insulin glargine and lixisenatide used to improve blood sugar control in adults with type 2 diabetes.

United States

$1,680

per month

India

$638

per month

You save

$1,043

62% cheaper in India

273.4K US scripts/yr$285.1M potential annual savings$459.4M US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$1,680per month

India price$638per month

You save$1,04362% less

Based on 30 units per month. US $56.01 vs India $21.26 per unit.

How many months / courses?

Total over 1 periodSave $1,043$1,680 → $638

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $6,256
Estimated travel cost: − $2,300
Net savings after travel: $3,956

Even after travel, you could come out ahead by about $3,956.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Insulin Glargine Lixisenatide is filled about 273.4K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$459.4M

If sourced from India

$174.3M

Potential annual savings

$285.1M

−62%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.